Editas Medicine, Inc. (EDIT)
3.14
+0.11
(+3.63%)
USD |
NASDAQ |
May 08, 10:43
Editas Medicine Research and Development Expense (Annual) : 84.68M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Puma Biotechnology, Inc. | 62.07M |
| Bristol Myers Squibb Co. | 9.492B |
| Black Diamond Therapeutics, Inc. | 33.23M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |